AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 4 - (NewsRx.com & NewsRx.net) -- Oral fluconazole is a safe and effective empiric treatment for persistent neutropenic fever.
According to a study from Israel, "Neutropenic patients who continue to be febrile despite adequate broad-spectrum antibacterial treatment require empirical antifungal therapy. The aim of the present study was to evaluate the safety and efficacy of oral fluconazole for empirical antifungal therapy in neutropenic patients with persistent fever.
"A prospective cohort design was used. The study sample included 250 consecutive patients with high-risk stage II, III, or responding metastatic breast cancer who received high-dose chemotherapy (HDC) with autologous peripheral blood progenitor stem cell transplantation."
"Those with neutropenic fever lasting more than 72 hours despite broad-spectrum antibacterial coverage were treated with fluconazole. Treatment was continued until fever dropped and/or neutrophil count recovered with blood cultures remaining negative," reported S.M. Stemmer and colleagues.
"Antifungal treatment was required in 173 patients (69%). There were no cases of documented deep systemic fungal infection. Two patients (
"Thirty-one patients (18%) were unable to complete the oral fluconazole protocol because of severe mucositis," said investigators, and they received intravenous fluconazole at the same dose, with similar efficacy."
"Oral fluconazole is a safe and effective alternative to ...
Source: HighBeam Research, Oral fluconazole safe/effective empiric treatment for neutropenic...